Source:http://linkedlifedata.com/resource/pubmed/id/20974843
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
52
|
pubmed:dateCreated |
2010-12-20
|
pubmed:abstractText |
CD4 is a co-receptor for binding of T cells to antigen-presenting cells and the primary receptor for the human immunodeficiency virus type 1 (HIV). CD4 exists in three different forms on the cell surface defined by the state of the domain 2 cysteine residues: an oxidized monomer, a reduced monomer, and a covalent dimer linked through the domain 2 cysteines. The disulfide-linked dimer is the preferred immune co-receptor. The form of CD4 that is preferred by HIV was examined in this study. HIV entry and envelope-mediated cell-cell fusion were tested using cells expressing comparable levels of wild-type or disulfide bond mutant CD4 in which the domain 2 cysteines were mutated to alanine. Eliminating the domain 2 disulfide bond increased entry of HIV reporter viruses and enhanced HIV envelope-mediated cell-cell fusion 2-4-fold. These observations suggest that HIV enters susceptible cells preferably through monomeric reduced CD4, whereas dimeric CD4 is the preferred receptor for binding to antigen-presenting cells. Cleavage of the domain 2 disulfide bond is possibly involved in the conformational change in CD4 associated with fusion of the HIV and cell membranes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1083-351X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
24
|
pubmed:volume |
285
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
40793-9
|
pubmed:meshHeading |
pubmed-meshheading:20974843-Antigens, CD4,
pubmed-meshheading:20974843-Cysteine,
pubmed-meshheading:20974843-Disulfides,
pubmed-meshheading:20974843-HEK293 Cells,
pubmed-meshheading:20974843-HIV-1,
pubmed-meshheading:20974843-Humans,
pubmed-meshheading:20974843-Protein Multimerization,
pubmed-meshheading:20974843-Protein Structure, Tertiary,
pubmed-meshheading:20974843-Virus Internalization
|
pubmed:year |
2010
|
pubmed:articleTitle |
Reduced monomeric CD4 is the preferred receptor for HIV.
|
pubmed:affiliation |
Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|